INTrEPID Data Supports Expanded LVAD Medicare Coverage Request
This article was originally published in The Gray Sheet
Executive Summary
WorldHeart expects CMS to issue by Nov. 12 a coverage decision on left-ventricular assist devices (LVAD) implanted as a destination therapy